Literature DB >> 30019304

Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with Esophageal Cancer.

Yusuke Ishibashi1, Hironori Tsujimoto2, Shuichi Hiraki1, Isao Kumano1, Yoshihisa Yaguchi1, Hiroyuki Horiguchi1, Shinsuke Nomura1, Nozomi Ito1, Eiji Shinto1, Suefumi Aosasa1, Junji Yamamoto1, Hideki Ueno1.   

Abstract

BACKGROUND: It is reported that several systemic immunoinflammatory measures, including systemic immune-inflammatory index (SII), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio, and C-reactive protein (CRP)-to-albumin ratio (CAR), are associated with survival in patients with various types of cancer.
OBJECTIVE: The aim of the present study was to clear which systemic immunoinflammatory measures had the greatest prognostic values. In addition, we examined which component had the greatest prognostic power in patients with esophageal cancer.
METHODS: Preoperative systemic immunoinflammatory measures were evaluated in 143 patients undergoing esophageal resection for esophageal cancer from 2009 to 2014. Univariate and multivariate analyses were performed to determine the prognostic significance of these markers. Receiver operating characteristic (ROC) curves were plotted, and the area under the ROC curves (AUROCs) were compared to verify the accuracy of each measure in predicting overall survival (OS).
RESULTS: In univariate analysis, preoperative SII, NLR, and CAR were the predictors of OS in patients who underwent esophagectomy for esophageal cancer (p < 0.05, respectively), whereas in multivariate analysis, CAR and pathological tumor depth were the significant predictors of OS (hazard ratio [HR] 1.994, p = 0.03 vs. HR 1.967, p = 0.02, respectively). According to AUROC, the CRP (0.66) and albumin levels (0.66) were more important systemic immunoinflammatory measures than neutrophil (0.58), lymphocyte (0.63), and platelet (0.56) levels.
CONCLUSION: Among systemic immunoinflammatory measures, CAR was the most significant predictor of OS in patients with esophageal cancer. CRP and albumin levels were more important components of systemic immunoinflammatory measures.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30019304     DOI: 10.1245/s10434-018-6651-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  25 in total

1.  Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study.

Authors:  Susumu Inamoto; Kenji Kawada; Ryosuke Okamura; Koya Hida; Yoshiharu Sakai
Journal:  Int J Colorectal Dis       Date:  2019-06-08       Impact factor: 2.571

Review 2.  Making cold malignant pleural effusions hot: driving novel immunotherapies.

Authors:  Pranav Murthy; Chigozirim N Ekeke; Kira L Russell; Samuel C Butler; Yue Wang; James D Luketich; Adam C Soloff; Rajeev Dhupar; Michael T Lotze
Journal:  Oncoimmunology       Date:  2019-01-22       Impact factor: 8.110

3.  Impact of Antiplatelet and Anticoagulant Therapies on Platelet-related Prognostic Markers in Patients With Esophageal Cancer.

Authors:  Yusuke Ishibashi; Hironori Tsujimoto; Keita Kouzu; Yujiro Itazaki; Satoshi Tsuchiya; Seiichiro Fujishima; Yoshihisa Yaguchi; Hidekazu Sugasawa; Shinsuke Nomura; Nozomi Ito; Manabu Harada; Hiromi Nagata; Eiji Shinto; Yoji Kishi; Hideki Ueno
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

4.  Survival Prediction Capabilities of Preoperative Inflammatory and Nutritional Status in Esophageal Squamous Cell Carcinoma Patients.

Authors:  Kotaro Sugawara; Koichi Yagi; Yasuhiro Okumura; Susumu Aikou; Hiroharu Yamashita; Yasuyuki Seto
Journal:  World J Surg       Date:  2022-01-09       Impact factor: 3.352

5.  Postoperative pneumonia causes the loss of skeletal muscle volume and poor prognosis in patients undergoing esophagectomy for esophageal cancer.

Authors:  Seiichiro Fujishima; Hironori Tsujimoto; Ken Nagata; Hidekazu Sugasawa; Shinsuke Nomura; Nozomi Ito; Manabu Harada; Takao Sugihara; Yusuke Ishibashi; Keita Kouzu; Hiroshi Shinmoto; Yoji Kishi; Hideki Ueno
Journal:  Gen Thorac Cardiovasc Surg       Date:  2020-09-10

6.  Comparative Analysis of Immunoinflammatory and Nutritional Measures in Surgically Resected Esophageal Cancer: A Single-center Retrospective Study.

Authors:  Makoto Sakai; Makoto Sohda; Hideyuki Saito; Yasunari Ubukata; Nobuhiro Nakazawa; Kengo Kuriyama; Keigo Hara; Akihiko Sano; Kyoichi Ogata; Takehiko Yokobori; Ken Shirabe; Hiroshi Saeki
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

7.  A Novel Systemic Inflammatory Score Combined With Immunoinflammatory Markers Accurately Reflects Prognosis in Patients With Esophageal Cancer.

Authors:  Takafumi Suzuki; Yusuke Ishibashi; Hironori Tsujimoto; Shinsuke Nomura; Keita Kouzu; Yujiro Itazaki; Takao Sugihara; Manabu Harada; Nozomi Ito; Hidekazu Sugasawa; Yoji Kishi; Hideki Ueno
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

8.  Development and Validation of a New Integrative Score Based on Various Systemic Inflammatory and Nutritional Indicators in Predicting Prognosis in Patients With Resectable Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study.

Authors:  Ji Feng Feng; Liang Wang; Qi-Xun Chen; Xun Yang
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302

9.  Prognostic Significance of C-reactive Protein-to-prealbumin Ratio in Patients with Esophageal Cancer.

Authors:  Tomoyuki Matsunaga; Hiroshi Miyata; Keijiro Sugimura; Masaaki Motoori; Kei Asukai; Yoshitomo Yanagimoto; Kazuyoshi Yamamoto; Hirofumi Akita; Junichi Nishimura; Hiroshi Wada; Hidenori Takahashi; Masayoshi Yasui; Takeshi Omori; Masayuki Ohue; Yoshiyuki Fujiwara; Masahiko Yano
Journal:  Yonago Acta Med       Date:  2019-12-13       Impact factor: 1.641

10.  Significance of a preoperative systemic immune-inflammation index as a predictor of postoperative survival outcomes in gastric cancer.

Authors:  Hiroyuki Inoue; Toshiyuki Kosuga; Takeshi Kubota; Hirotaka Konishi; Atsushi Shiozaki; Kazuma Okamoto; Hitoshi Fujiwara; Eigo Otsuji
Journal:  World J Surg Oncol       Date:  2021-06-12       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.